RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,863,760 | -11.8% | 2,335,132 | -13.9% | 0.70% | -1.0% |
Q2 2023 | $20,252,276 | +9.6% | 2,711,148 | -2.1% | 0.70% | +9.5% |
Q1 2023 | $18,478,908 | -11.6% | 2,770,451 | +2.2% | 0.64% | -19.3% |
Q4 2022 | $20,896,714 | -12.8% | 2,710,339 | +20.4% | 0.80% | -20.4% |
Q3 2022 | $23,961,000 | +16.1% | 2,251,971 | -11.2% | 1.00% | +28.0% |
Q2 2022 | $20,640,000 | +34.9% | 2,535,622 | +18.7% | 0.78% | +66.2% |
Q1 2022 | $15,298,000 | -38.1% | 2,136,604 | +48.0% | 0.47% | -31.7% |
Q4 2021 | $24,733,000 | +62.4% | 1,443,863 | +118.2% | 0.69% | +60.4% |
Q3 2021 | $15,226,000 | -11.7% | 661,703 | +40.0% | 0.43% | +7.5% |
Q2 2021 | $17,248,000 | – | 472,552 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |